Targeting RAS for Pancreatic Cancer Interception
0 citations
Abstract
Multiple strategies to target RAS are now available to treat pancreatic cancer. As pancreatic precancers also have KRAS mutations, these tools hold great promise for cancer interception.
// Source
Authors: Sandra Misale, Neeha Zaidi, Elizabeth M. Jaffee, Alison Patricia Klein, Laura DeLong Wood
Institutions: Johns Hopkins University, University of Baltimore, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center